| metastatic/advanced mGC or mGEJC | |||
| mGC or mGEJC - L1 - PDL1 positive | mGC or mGEJC - L2 - all population | mGC or mGEJC - L2 - PDL1 positive | |
| pembrolizumab based treatment | |||
| pembrolizumab alone | KEYNOTE-062 ... KEYNOTE-062 ... | KEYNOTE-061 ... | KEYNOTE-061 ... |
| pembrolizumab plus SoC | KEYNOTE-062 ... KEYNOTE-062 ... | ||
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
